FDA Clearance Tracker · P030019-S012
ORTHOVISC HIGH MOLECULAR WEIGHT HYALURONAN
Last checked: Nov 20, 2026Latest source record: Nov 8, 2006 (this decision)Source: openFDAMethods & limitations
Decided
Nov 8, 2006
Approved
Time to decision
91 days
Received Aug 9, 2006. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P030019-S012
- Device name
- ORTHOVISC HIGH MOLECULAR WEIGHT HYALURONAN
- Applicant
- Anika Therapeutics, Inc.
- Applicant location
- Beford, MA
- Received
- Aug 9, 2006
- Decided
- Nov 8, 2006
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P030019
Device type
- Device type
- Acid, hyaluronic, intraarticular (MOZ)
- Device class
- Class III
- Specialty
- Orthopedic Surgery
FDA's approval statement
As written in FDA's record.
APPROVAL FOR ELIMINATION OF THE SECOND STERILIZATION STEP FROM THE FINAL PACKAGING PROCESS, AND AN UPDATE TO THE PACKAGE LABELING TO REFLECT THIS CHANGE.
Source documents
Other decisions for Anika Therapeutics, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261869 · Decided Sep 17, 2026 · 105 days after receipt
Device type: Fastener, Fixation, Nondegradable, Soft Tissue (MBI) · Orthopedic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.